Showing posts with label Stryker. Show all posts
Showing posts with label Stryker. Show all posts

Wednesday, 1 November 2017

The Bees Kneez


To market to market to buy a fat pig. Yesterday Stats SA released the Quarterly Labour Force Survey (QLFS), showing that our unemployment rate stayed constant at 27.7%. The good news is that over the last year, 358 000 more South African's have a job; there are still 6.4 million people looking for a job and that number jumps to 8.6 million if you include 'Discouraged work-seekers'. To be considered unemployed, you need to have actively looked for a job in the last month. When you add the people who have given up looking for a job to the official number of unemployed people, our unemployment rate sits at 38%! That means out of every five people who want to work, only three are able to find a job.



As we have seen coming through in our GDP data, the area of most growth is 'Finance and Business Services', where over the last year 140 000 jobs were added. It is no surprise to see that employment in the construction sector dropped over the last year, down by 127 000 people. Construction attracts long-term capital investment, with business confidence at multi-decade lows there are fewer people deploying long-term capital at the moment.



Market Scorecard. US markets have continued their recent trend of not following a down day with another down day, I can't remember the last time the US had two down days in a row. The Dow was up 0.12%, the S&P 500 was up 0.09%, the Nasdaq was up 0.43% and the All-share was up 0.17%.




Company corner

Bright's Banter

Stryker 3Q numbers

- Completed the purchase of NOVADAQ Technologies on the 1st of September 2017
- Acquired French company Vexim on the 24th of October 2017 to be completed in Q4
- Sage recalls and hurricane impact expected to result in approximately $45 Million in lost sales in Q4


On Friday the 27th of October Stryker reported better than expected numbers for the third quarter and that sent the share price soaring over 7% on the day. A good day for Vestact clients that hold this counter in our offshore portfolios. They also increased its guidance for the 2017 full year with expected sales between 6.5% to 7% and earnings of $6.45 to $6.50.

How did the company do compared to Wall Street's Expectations?

1) Third-Quarter Net Sales grew by 6.1% to $3 Billion (5.8% in constant currency) which beat expectations by $30 Million

- Orthopaedics grew by 5.1%
- MedSurg grew by 6.7%
- Neurotechnology and Spine grew by 6.9%

2) Third-Quarter Net Earnings Per Share grew by 21.3% to $1.14

3) Third-Quarter Adjusted Net Earnings Per Share grew by 9.4% to $1.52, a modest beat of $0.02



All three reporting division of Stryker did well in the third quarter notwithstanding the negative impact of the Sage product recalls in their MedSurg division and the hurricane that halted production in the quarter. Production volumes were also up throughout the company. Mako Robots which are mostly used in knee surgeries are still driving sales in a big way as the company sold 33 Mako Robots of which 23 were installed in the U.S. Total knee procedures increased more than 50%.

On the 1st of September 2017 Stryker acquired NOVADAQ for a purchase price of $678 million. We wrote a comprehensive piece here on what NOVADAQ does and how it complements the Stryker's Endoscopy's portfolio. NOVADAQ is said to have contributed positively to Endoscopy sales as those were up 13.4%.

Stryker also acquired a French company VEXIM for EUR183 Million in exchange for 50.7% of the shares in the company. VEXIM is a specialist in design of minimally invasive spine surgery medical devices. The prominent brand is called SpineJack which the company describes as a mechanical expandable VCF implant for vertebral fracture reduction and stabilisation. This spine technology will complement the Stryker interventional spine business and transform its position in the space.

Stryker is still our preferred company in the medical devices space because the business has the margins of an iPhone, strong brands which drive volumes and better market positioning over competitors like Medtronic, Thermo Fisher, or Zimmer. Their devices are still the favourite across the medical community.




Linkfest, lap it up

One thing, from Paul

Do you subscribe to the Business Day online? If not, you should. Its cheap (R120 a month I think, you put in your credit card details), and allows you access to daily articles, plus the weekly in-depth Financial Mail articles.

Analysis of our news stories of the day by top analysts, that's worth supporting. Like this piece from my UCT contemporary, Nusas comrade, Business Day deputy editor Carol Paton - Structural changes will save SA, not Gigaba's grim vision

She is writing here about the aftermath of the mid-term budget policy speech last week.

    "Last Wednesday was a difficult day for Finance Minister Malusi Gigaba. He knew he had bad news to deliver to the nation; this was not going to be his moment of glory.

    "He struggled through the pre-budget parliamentary briefing, muddling concepts and dropping words and phrases such as "spending cuts" and "fiscal stimulus", apparently without noticing the contradictions.

    "But if Wednesday was bad, Thursday was much worse as the extent of the fallout over the medium-term budget policy statement became known. The market reeled.

    "These are big political decisions that require courage and unity of purpose at the top of government. With the December conference looming there is not a single voice in the Cabinet that would make any decision that might affect the ANC's political base. Apart from this, courage, unity and commitment are in short supply in this Cabinet.

    "The outlook then is not good for Gigaba or SA. Come February, chances are we will be staring at the same set of numbers, possibly made even worse by a November credit ratings downgrade."


Sobering stuff!




Michael's Musings

As we move toward more renewable energy, much has been written about lithium and cobalt. This is the first time I have seen someone write about nickel, which is surprising given how much of the battery is made up of nickel - Nickel: The Secret Driver of the Battery Revolution.






Home again, home again, jiggety-jog. It is a lovely green start to our market, up over 1% and with in touching distance of 60 000 points. Naspers have also broken through the R3 500 a share level, go you good thing! Then this evening the US Fed announces if they will raise rates. The market is expecting nothing to change tonight but that a rate rise will happen in the middle of December. Sticking with the Fed, Trump is expected to announce the next chairperson by the end of the week.




Sent to you by Team Vestact.

Email us

Follow Michael, Byron, Bright and Paul on Twitter

078 533 1063

Wednesday, 25 October 2017

Stryke While The Iron is Hot


To market to market to buy a fat pig. Generally, the Medium Term Budget Policy Statement (MTBPS) is a bit of a non-event because no major policy changes are announced. Today though it will be different, rating agencies will be watching closely before their 24 November rating review. The maiden budget speech from Mr Malusi Gigaba, will be a tough one. How good will his icebreaker joke be?

Standard Bank forecast that our current revenue shortfall is around R45 billion, which could increase to over R70 billion next year. When you collect less tax than expected, there are two options. Either you can run things at a wider deficit, or you need to pull back expenditure. We already have a wide deficit and are teetering on the edge of being classified as junk by all three major rating agencies; it would seem there is only one choice, cut expenditure. Between SAA, Eskom and the SABC, our budget is already needing some TLC. All eyes will be on Gigaba for where he plans to cut costs, not an easy task for any government.

Market Scorecard. Markets returned to their green ways yesterday. The Dow was up 0.72%, the S&P 500 was up 0.16%, the Nasdaq was up 0.18% and the All-share was down 0.16%. To get the ball rolling on company news, Visa releases their 4Q numbers tonight, before Amazon, Google, Twitter, Stryker and Cerner report on Thursday. I am particularly keen to hear from Amazon how the integration of Whole Foods has gone.




Linkfest, lap it up

One thing, from Paul

It's amazing how much money is managed by firms that have a relatively low profile. For example, privately-held Edward Jones is based in St. Louis, Missouri in the central part of the USA. It has 15,000 advisors, over 7 million clients and and 1 trillion US dollars in assets under management - Edward Jones Hits $1 Trillion in Assets




Byron's Beats

Stryker, one of our US based healthcare stocks has been doing well lately. They operate in a segregated sector (medical devices) with lots of technological innovations happening at the moment. Of course they do their own R&D but being a massive player, they are also consolidating smaller businesses that have proven track records and supply agreements with hospitals.

Yesterday it was announced that they have bought a stake in a French business called VEXIM which specialised in mechanical implants for spinal injuries. Stryker have bought half the business for around 90 million Euro. This consolidation tactic is one of the reasons we own the stock, long may it continue - Stryker to acquire VEXIM




Michael's Musings

When most people hear the term blockchain they think of cryptocurrencies, it is a whole lot more than that though. Blockchain is the technology that uses computers from all over the world to store data and execute tasks; each computer gets a tiny fraction of the data to store - The Power of Smart Contracts on the Blockchain.



Here is a graph from the Ray Dalio piece, Bright spoke about yesterday. The graph shows that income inequality is not a new problem, at the turn of the 20th century, when there were the titans of industry like Ford, Carnegie and Rockefeller, inequality was worse - The top 0.1% of American households hold the same amount of wealth as the bottom 90%.



It is interesting to see how different nations feel about autocratic rule. Each nation's history plays a prominent role in what type of rule the people know and feel comfortable with. I watched a documentary recently on Russia; after overthrowing the Tsar, the people still expected the new communist rule to have an autocratic ruler because they were used to having an individual calling all the shots - Where Support For Autocracy Is Strongest

Infographic: Where Support For Autocracy Is Strongest  | Statista You will find more statistics at Statista




Bright's Banter

The future is here! Algorithms are taking over analogue processes and simplifying them using formulas. Artificial intelligent (AI) learns faster than any human, which will help us make better decisions in the future.

The newly developed computer by Deep Mind, AlphaGo Zero has beaten the old AlphaGo version in a game of Go 100: 0! This shows what you can achieve with significant development and sharp minds programming these computers - AlphaGo Zero Learning Scratch




Home again, home again, jiggety-jog. Our All-share is out the blocks today in the green; thanks to Tencent in Hong Kong being higher by 1% today, Naspers is also 1% higher. Year to date, Tencent is up 85% and Naspers is up 62%. Apart from the MTBPS, we have 3Q GDP numbers from the UK and oil inventory numbers from the US.




Sent to you by Team Vestact.

Email us

Follow Michael, Byron, Bright and Paul on Twitter

078 533 1063

Thursday, 22 June 2017

StrykerNova

"Stryker has bought a small business called NOVADAQ, paying a massive premium, almost double the share price from Friday last. From the all time highs of 22.81 Dollars a share in March of 2014 however, it is half, the share price was 6.23 on Friday at the close. Of course, it is all relative. Still, the price tag is 11.75 Dollars a share, or 701 million Dollars. There is a break fee of 21 million Dollars, if the deal fails."




To market to market to buy a fat pig Stocks in Jozi got a lift yesterday, we closed around half a percent to the good by the time the closing bell had rung. The Rand had a strong 13 in front of it, to the Dollar of course. There was not too much going on from a corporate news point of view, the Treasury was trying to appease wobbly sentiment, as was the Reserve Bank. I am not too sure where the Public Protector comes with the idea that the state managing a countries finance is a good idea, or even that there are a "lot" of authors who advocate this type of strategy. As the governor of the Reserve Bank said, price stability is very important for the most vulnerable in society. I suppose, the ruling against ABSA does involve the Reserve Bank, to be fair to her, she was just making observations. Free market and fierce independence will tell you that she has overstepped the mark in terms of observations.

You read the following two paragraphs and tell me what "leading authors" and what working examples of states that successfully do this, that you know. There are two separate sentences next to one another that have caught the eye of many in financial journalism and indeed across the globe, enough so that the finance minister gave an interview to Bloomberg two nights back:

    "It is in this believe that once the state takes control of creating money and credit, numerous benefits aimed at alleviating economic ails of ordinary economically disadvantaged people may be achieved, unlike our current purely commercial transaction system which only seeks to improve a particular financial sector."


And

    "Leading authors advocating and promoting the ideology of state banks and nationalisation of monetary currency believe that the notion of last resort's status that is inherent to central banks internationally would cease to exist if governments take sole power in creating money through the establishment of state banks."


Leading authors have no practical evidence to suggest it works, in fact, the opposite is always true. For working examples of state inefficiencies look across the globe at failed state airlines and hyperinflation when the state "controls" the broader economy. Of course those people who point to Scandinavian countries being very government involved may well be right, small populations (around 27 million combined) and natural resources, with high education levels and zero tolerance for mismanagement. High taxes, big social security net. Population density? About the same as Russia. Bad climate ..... Politics, religion and dinner parties do not mix, we try and keep this message as practical as possible.

Top gainers on the day were the likes of Bidcorp and MTN (an upgrade), Anglo American and AngloGold Ashanti, the top losers were the likes of Vodacom and Old Mutual. Data prices must fall? It turns out that they have fallen. Whilst it is true that we do need to be more competitive, South Africa is a big country with many to cover. ICASA has both suggested that prices have fallen as there is real competition. In fact, by not opening bigger parts of the spectrum, ICASA has been in part to blame for higher prices. The expiration of data, that is another argument altogether. Data doesn't feel like food!




Across the oceans and seas, vast and wide, stocks in New York, New York were again mixed amongst the majors. There was a lot of focus on the box on an unlisted business and their woes, Uber CEO was pushed/taking a leave of absence, Travis Kalanick has suffered some huge personal blows lately. He is young by CEO standards. The internet can be brutal, his current title on his Wikipedia account is "Unemployed". Ouch! Uber is an incredible application with multiple uses, the internal company "issues" have been laundered everywhere. It has been very bad press and rightfully so, a macho culture belongs somewhere else, not in the modern era, more likely in the trash can. I have a feeling that Uber will emerge stronger and that the ease of use of the application has shaken up a sleepy industry.

Anyhows, the business is not listed, all of our interest in this is just a passing one. For more, the New York Times has a great piece - Inside Travis Kalanick's Resignation as Uber's C.E.O. As someone pointed out, no COO, no CFO, no CEO, exactly what you would want from a driverless lift sharing business. As for the cities and countries that pander to the needs of old technology and opaque pricing (I am talking metered taxis friends), their struggle is the same as that of the saddle maker over 100 years ago.

At the closing bell, with energy dragging the market lower again (oil prices falling regularly), the Dow gave up one-quarter of a percent, the broader market S&P 500 lost 0.06 percent, whilst the nerds of NASDAQ rallied three-quarters of a percent. Healthcare and tech ruled the roost, it was "newer" tech that rallied, the likes of Apple, Alphabet (Paul refuses to call it that, keeps on saying Google), Microsoft and Facebook. As well as Alibaba, Jack Ma is always busy! Amazon and Nike will do business directly for the first time, the Foot Locker share price took that one badly, down 5 percent on the day. This is not new, the Foot Locker share price has lost one-third in three months, new retail avenues (online) is worrying for brick and mortar stores. The Foot Locker Larry Bird 4 I said facetiously, with reference to Under Armour Steph Curry and the Nike Jordan. It turns out that Larry wore Converse, which is owned by Nike.




Company corner

Stryker has bought a small business called NOVADAQ, paying a massive premium, almost double the share price from Friday last. From the all time highs of 22.81 Dollars a share in March of 2014 however, it is half, the share price was 6.23 on Friday at the close. Of course, it is all relative. Still, the price tag is 11.75 Dollars a share, or 701 million Dollars. There is a break fee of 21 million Dollars, if the deal fails.

Mr. Market thinks that the deal will close, the current price is trading above the offer price .... in fact, Mr. Market thinks that there may well be someone else interested, if even marginally. Or the shorts closing out? According to Novadaq Technologies Inc Short Interest information from the NASDAQ website, at the end of May, there were 28 days current volume to cover short interest. i.e. it would take the shorts 28 days to buy back the shares at the daily average volume.

Forget that, what does NOVADAQ do and why would Stryker find this an interesting purchase? NOVADAQ has multiple technologies, including something called Spy Elite, that enables surgeons to make better decisions using imaging technology. Both in the actual surgical situation and assisting the healing, leading to quicker turnaround times for recovery and more importantly for all concerned, reducing unnecessary costs. The basics of it are as follows (I hope I am explaining it properly), when closing a skin flap, the surgeon needs to be sure that the skin won't die, or the skin that is being closed has superior blood flow. With this technology, they can ensure that there are steady blood flows and as such the necrosis rates are greatly reduced. I hope I understood that properly.

The procedures for these technologies are covered on the website, and include Breast Reconstruction, Cardiac Surgery, Colorectal Surgery, Laparoscopic Cholecystectomy, Limb Salvage and Diabetic Foot Ulcers. The Stryker release describes it more eloquently than I could ever: "NOVADAQ is a leading developer of fluorescence imaging technology that provides surgeons with visualization of blood flow in vessels, and related tissue perfusion in cardiac, cardiovascular, gastrointestinal, plastic, microsurgical, and reconstructive procedures."

Some of these technologies complement the existing Stryker portfolios, some are new. There are great cross sale opportunities across the existing portfolio. Whilst this is by no means a "big deal", it is a mere percent and a half of their market cap, this is the style the company follows. Find a great technology, buy it and roll it out on a bigger scale. All for the advancement of humanity. That is the kind of business that one wants to own! Profitable, cutting edge technology meets critical healthcare needs. We continue to accumulate and stay the course.




Linkfest! Lap it up

Tencent is in becoming more mainstream as Wall Street understands the company better - Tencent's Startup Investment Frenzy Now Reaches Outer Space. I think as South Africans we are incredibly fortunate to be able to invest in Tencent through Naspers.

Byron found this great piece on the future of trucking. The one section that looks very interesting is the ability for trucks to travel in convey, very close to each other thus reducing drag and saving on fuel - Here's how Tesla, Uber, and Google are trying to revolutionize the trucking industry.

As the saying goes, being early is as good as being wrong. Vestact has been early on our Tobacco call, things might be changing though - Quitting Tobacco Stocks Is Easier at These Prices.




Home again, home again, jiggety-jog. On the news front we have initial jobless claims out of the US today, a number that is becoming less and less significant as the US job market has reached full employment. Bigger news to look forward to is the FY numbers out of Naspers tomorrow.




Sent to you by Sasha, Byron and Michael on behalf of team Vestact.

Email us

Follow Sasha, Michael, Byron, Bright and Paul on Twitter

078 533 1063

Thursday, 11 May 2017

Stryker, Cutting Edge

"I am excited by the business of Stryker. They really are at the (excuse the pun) cutting edge of healthcare technological advances. Less invasive surgeries will lead to more procedures and more importantly for a company like Stryker, more quality equipment sold."




To market to market to buy a fat pig OK. I have seen a lot of people upset with the way that Trump just fired the FBI director. I hear their pain, it is part of the processes of the separation of power, who can and cannot make the decisions that have implications, not only for the short term, equally in the long run. According to the chattering classes, this was supposed to be very negative and as such, they were expecting a big sell off in the equities markets. So do not be surprised with reading headlines of shock/horror such as this one from Barron's: Shrug: Dow Drops 30 Points as Not Even Comey's Firing Can Move This Market.

This Market? It seems like the author, Ben Levisohn, is somehow bemused that a FBI agent firing doesn't see equities sell off. OK, what is the theory? Quite simply, this may be a roadblock in trying to get stuff done. If the president of the most powerful economy on the planet (no, not North Korea) is making executive decisions that peeve some folks, that may not lead to tax reform legislation getting passed. Look, there are tons of what ifs in there, and what could and might happen. From where we sit, you should never invest on the basis of what politics may, or may not pan out. Levels of markets are "targeted" by market strategists, based on momentum, or whatever.

Ben does not seem like the biggest optimist to me. I am naturally cautiously optimistic. As an investor, you have to always believe, after you have done your thorough research, that the thesis will hold true over time. Otherwise, you should go into the business of candles, paraffin, shotgun shells and baked beans. People spend way too much time on the Fed, or politics or forecasting, or targets or worrying about what can happen next. Investing is not like following your favourite sports teams. There are more ups and downs there. You have little control over team selection in sports team supporting, you can choose your entire portfolio without compromising the team inclusion or exclusion. You are Arsene Wenger. Goodness, I hope that Arsenal qualifies for Champions League, that would make some people sit down.

In closing this piece, know a few things about investing. You have absolutely no control over market levels and share price movements. Zero. You have complete control over what you own and what your holding period is likely to be. Peter Lynch once said in an interview: "I mean I deal in facts, not forecasting the future. That's crystal ball stuff. That doesn't work. Futile." He was a great investor on the back of human emotion and could recognise it better than most. In other words, he could see through the fear and greed. Nobody knows what is going to happen next and I think for many retail clients, that scares the proverbial investing pants right off them. No, it is too risky. In reality, that couldn't be further from the truth.

You have control over your investments. The calls I have fielded over the years about anxiety and wanting to sell to go to cash are forgotten in the mists of time as equity markets rise. Markets go up and down, the company that you own, lives, breathes, has real life customers and employees and managers, they make real life decisions on spending shareholder money to create new services and products. There are real life consumers of their products and services, looking for quality relative to the price they are willing to, or can, pay. So whilst Ben worries what may move This market (and that is his job), you must know you own a piece of a business, that happens to have a second by second quoted price with deep liquidity. And it is that simple. What you choose to do with it from there, well .... that is up to you.

I definitely subscribe to theory and practices of a simple line in the 1988 Warren Buffett annual Chairman's letter:

    "In fact, when we own portions of outstanding businesses with outstanding managements, our favorite holding period is forever. We are just the opposite of those who hurry to sell and book profits when companies perform well but who tenaciously hang on to businesses that disappoint. Peter Lynch aptly likens such behavior to cutting the flowers and watering the weeds."


And there ends the investing lessons for the day. I am sure this is a drum we have beaten on five years/ten years ago and before, and over the next decade too. Keep on keeping on.




OK, a quick market look then. The Dow gave up 32 points (0.16 percent), as you saw above. The broader market S&P 500 added just over one-tenth of a percent, whilst the nerds of NASDAQ added 0.14 percent by the close. Disney was in the spotlight, many people still very anxious about the ESPN business. This business is intriguing for me, the longevity and the ability to span multiple generations across many different cultures. Heroes and villains for children of all ages. The stock sank over two percent. NVIDIA soared nearly 18 percent to an all time high, those results (we wrote about them yesterday) were very well received.

Locally, stocks added 0.15 percent as a collective. Industrials lost around that amount (0.15 percent), the Rand was stronger (on account of the Dollar being weaker). AngloGold, Amplats and Remgro were the big winners on the day, South32, Steinhoff and Shoprite were the big losers on the day. There was a complicated and multiple moving parts trading update from Netcare, the stock barely moved on the day. Over the last three years the stock is basically flat in Rand terms.




Company Corner

Homer Stryker was a pretty late starter, as far as business formation goes. Born in 1894, he only discovered a decade and a half into his medical career that he was most interested in orthopaedics. Fair enough, rather late than never! And sooner than Ray Croc (the McDonald's guy!). Little did Dr. Homer Stryker know that medical science would get to the point nowadays where the company he founded (and was named after him), Stryker, would be at the point where the company is responsible for Craniomaxillofacial and Spinal implats. We are talking about reconstruction of skeletal structures here, ones in which people can have multiple "parts". Knees, hips, your foot, your ankle, pins in bones, machines that help surgery (Mako), which include truly futuristic technology, after and pre care (ambulance stretchers to beds), and the original power tools business.

It was Homer after all that that patented the oscillating saw, to remove plaster casts. The website under history notes the following (from 1947): "As a result of a late-night brainstorm, Dr. Stryker hit on an idea for a powered cast cutter. The first prototype, created on the premise that an oscillating saw blade cuts hard material but not soft surfaces, incorporates a motor from a malted milk mixer. The once long and laborious process to remove a plaster cast now takes only minutes with the cast cutter. The saw cuts hard cast material, but not human tissue, and is the forerunner to a broad line of surgical instruments." Thanks to Homer not sleeping at night, we can all be grateful for the amazing ranges of tools at surgeons and health caregivers disposal. And technological advances in software and computer based technologies.

The company will leverage off the same healthcare growth that our other investments in the sector will benefit from. At the end of the day, modern technology will save money and boost the outcomes for the better for all parties. Better outcomes from the patient to the healthcare insurance businesses. And definitely allowing the professionals and hospitals to focus on what is important, the outcome. Watch this video (it is obviously from the company) to see what is available to patients, the technological innovations that Stryker supplies to surgeons, for less invasive surgery - Aim Platform, scroll to the bottom of the page.

The business is really well diversified, within their three core divisions, namely MedSurg, Orthopaedics and Neurotechnology and Spine, no one subsegment is more than 14 percent of total sales. In fact, here is the breakdown from the 2016 annual report: Instruments - 14%, Medical - 14%, Endoscopy - 13%, Knees - 13%, Trauma & Extremities - 12%, Hips - 11%, Spine 7%, Neurovascular - 5%, Neuro Powered Instruments - 4% and Craniomaxillofacial at 2%. Various "other" makes up the balance.

MedSurg was the standout, thanks to new products and acquisitions in that area. Growth outside of the US in revenue terms was around ten percent better than the corresponding quarter. The business is essentially still very much a US based one, roughly 30 percent of the business is outside of the US. This is good, it means that their ability to continue to attract big business from other territories. Europe, Canada and Australia, where there are loads of rich people.

I am excited by the business of Stryker. They really are at the (excuse the pun) cutting edge of healthcare technological advances. Less invasive surgeries will lead to more procedures and more importantly for a company like Stryker, more quality equipment sold. Stay long and accumulate on weakness, this is a fabulous business with a very fair share price at current levels. You must own this company in your long term portfolio. It is a must!




Linkfest, lap it up

The AA regularly makes a nice breakdown of what we are paying for when we fill up our cars - The petrol price - all you need to know.



Here is a graphic showing that we drive on the wrong side of the road. A bit of Googling tells me that knights would keep left because their swords were in their right hands, people rebelling against the colonial system of doing things decided to then ride on the right hand side. Not sure how true it is but makes for a good story - Which Side Of The Road Do You Drive On?

Infographic: Which Side Of The Road Do You Drive On?  | Statista You will find more statistics at Statista




Home again, home again, jiggety-jog. How was that moon this morning sportslovers? It was lovely. No ... it was spectacular. Stocks across Asia are all higher, on balance, if not by a huge amount. The Nikkei nearly broke the 20 thousand mark again! A long way to go to the 1989 level of the high 30 thousands though.



Sent to you by Sasha, Byron and Michael on behalf of team Vestact.

Email us

Follow Sasha, Michael, Byron, Bright and Paul on Twitter

078 533 1063

Wednesday, 25 January 2017

Smashing Stryker

"What is clear to me, and to many, is that this continues to be a growth industry. Many more people can enjoy something that was only available to richer people of yesteryear"




To market to market to buy a fat pig Yesterday was decision day on rates, for the local market. Expectations were for no change, and that is exactly what happened, the SARB decided to leave the repurchase rate at 7 percent. Which means that for your debt, you get that rate plus what the bank adds on top of that, i.e. the prime lending rate. For each 1 million Rand in mortgage debt currently, you are (at 10.5 percent, which is the "par" rate), you are likely to be paying 9,983 Rand a month.


Nearly 10 thousand Rand a month on each one million Rand of mortgage debt, provided of course that you are paying over 240 months, which is 20 years. If you shorten that to 180 months (slash off one quarter of the time), your cost of servicing the debt rises to 11,053 Rand a month. An extra 11 odd percent per month to shorten the duration of the loan by 5 years.


What is even more amazing however is if you shorten the duration to 10 years (or half), the amount payable is 13,493 per month. You pay an extra 35 percent for ten years (per million Rand mortgage) and you can halve the time spent in mortgage debt. Wow. If then you flip it around and invest that 13,493 Rand a month (161,916 Rand a year) for ten years, and earn a very modest seven percent per annum, you will not only have your house after 20 years (and whatever that is worth), you will also have nearly 2.4 million Rand with which to compliment your retirement savings. Such is the power of paying mortgage debt down quickly, and then saving that money.


Of course most people should do this, they don't. Live happens in between. I used the Nedbank Loan Repayment Calculator and the MoneyChimp Compound Interest Calculator to arrive at these numbers, loose and fast, an indication I know, nonetheless it is pretty useful.


You can read through the South African Reserve Bank's Monetary Policy Committee statement and see if you are any the wiser after. You can even read (flip the table 90 degrees to the right) the Selected forecast results: MPC meeting January 2017. Please, though, do not use these assumptions and forecasts when buying a slice of a listed (or unlisted) business. A business works through these cycles, they are not roadblocked by them, growth and credit that is. The good news for the outlook is that the firmer Rand to the basket means inflationary concerns have abated. And that there has been some rain, more food at cheaper prices.


Stocks in Jozi, Jozi by the close were mixed, the overall market gains were driven higher by resource complex, which was up another 1.85 percent. The ALSI closed up 0.57 percent, comfortably above the 53 thousand point mark. Amplats, South32 and Kumba were having a stonker (noun - something which is very large or impressive of its kind) of a day, all up over five percent apiece. There were new 12 month highs for Anglo, BHP, Glencore, Capitec (again) and Tiger Brands too.




Across the drag (size of universe speaking), stocks in New York, New York had an impressive day. A record for the nerds of NASDAQ, that index closed at 5600 (and some change), up nearly nine-tenths of a percent. The broader market S&P 500 added two-thirds of a percent, whilst the Dow Jones Industrial Average managed a gain of 0.57 percent on the session. Dow 20K watch is back on the cards, the index is now only 88 points from that milestone. Alibaba had a good day after results that impressed all and sundry, AT&T and JNJ not so much. We will look at some of these, as well as Stryker, who reported after-hours. We will have all of the wraps, starting below.




Company Corner


Stryker reported numbers post the market close. In a recent JP Morgan healthcare conference, a couple of weeks back, the company gave a great breakdown of all of their business divisions. As "they" say in the classics, a picture is worth 1000 words, download it here: 35th Annual J.P. Morgan Healthcare Conference Presentation.



It is a business that is well diversified across different segments, hip and knee replacements are becoming increasingly minor procedures (if there is such a thing). Let us take a dive in - Stryker reports 2016 results and 2017 outlook. Net sales for the year were up nearly 14 percent, reported net earnings were 14.5 percent up on the year to 1.6 billion Dollars. Decent enough margins, they are selling everything from bone cement to hospital beds to complicated surgical equipment. Spinal implants, that looks next level!


The bionic man of yesteryear is to a certain extent a reality today, although these are the products that you are grateful for, you are less likely to rush out and use (get) them willingly. Whilst a hip and knee implant will change your life for the better, and lift the quality of your life, you do not want to get to the point in which you need them, if you get my drift.


Guidance for the year ahead was decent enough, the company expects earnings per share for the full year to be between 6.35 to 6.45 Dollars for the full year (1.40 to 1.45 Dollars in the first quarter). That compares to the 5.80 Dollars on the same metric, that being just reported for the full year to end 2016. At the closing price of 121.5 Dollars last evening, the stock trades just shy of 21 times earnings historic and on the company guidance in the midpoint of the range given, just less than 19 times.


Hardly a bargain, on a PEG ratio basis (Price to Earnings over Growth rate), it is closer to 1.8. Which again, is not "cheap", nor is it wildly expensive. Which is why I guess the market hardly budged after-hours on these numbers, if the company is likely to produce 10-15 percent earnings growth, the market is happy to rate the stock on a 19 multiple forward. With a dividend yield of only around 1.4 percent, you are certainly not buying this one for the income.


What is clear to me, and to many, is that this continues to be a growth industry. Many more people can enjoy something that was only available to richer people of yesteryear, from that same conference presentation that we spoke of above, the growth in Stryker revenues has been a sight to behold, this is from 1979 to last year:



The company continues to make acquisitions, they have now integrated the MAKO business into theirs wonderfully well (acquisition done back in 2013), having sold their incredible robotic arms that deliver bespoke knees and hips to their "customers". Check them out - Robotic-Arm Assisted Technology. There are 381 of these worldwide, so far, with 333 of them in the US. With their bigger business and bite sized acquisitions, they are able to roll out these products at a faster rate. We expect the company to continue to look at these, as and when they arise. The company spent roughly 15 percent of their market cap on acquisitions over the last three years.


This is a growth business that you are buying on a fairly "cheap" forward multiple. The growth thesis is also contained inside that their international presence is fairly limited, they are predominately a US based business, so there is plenty of scope to tap rich developed and richer middle income people in developing markets. We remain buyers of what is a great business with superb leaders, I like Kevin Lobo. Defensive in nature, growth in future.




Linkfest, lap it up


Our mottos around here include "keep on keeping on" and "be optimistic". It is natural that I would like a website that is full of Human Progress. This article link below deals swiftly with the doomsday prophet Paul Ehrlich, who delivered a speech nearly 5 decades back. Like Malthus who went before, we were all going to starve to death: "The battle to feed all of humanity is over. In the 1970s hundreds of millions of people will starve to death in spite of any crash programs embarked upon now. At this late date nothing can prevent a substantial increase in the world death rate..." And that is just the prologue, you can read the whole book here - The population bomb. So he is an idiot, right? As this article points out, people still want to hear him, and real policies were enacted - Paul Ehrlich Addressing Vatican Conference on Biodiversity. It is a real pity that we give bearish views so much substance. Stay long food businesses like Tiger Brands.


I suddenly figured yesterday when Paul asked for a "free link" (not a subscription one), that many of you would not have been able to incorporate the Byron Wien Announces Ten Surprises for 2017. No worries, follow that link there to the "free" resource. Point 6 is a little extreme? With all going on, who actually knows nowadays though, right? Like we said yesterday, point three is one I "like": "The Standard & Poor's 500 operating earnings are $130 in 2017 and the index rises to 2500 as investors become convinced the U.S. economy is back on a long-term growth path. Fears about a ballooning budget deficit are kept in the background. Will dynamic scoring reducing the budget deficit actually kick in?" Stay long, ignore the "noise" is essentially the mantra.


You know that a sport has gone main stream when universities have teams representing them and competing at a national level. Tencent owned, League of Legends is moving out of the realm of only being played and followed by 'nerds', to a more mainstream following - Big Ten Universities Entering a New Realm: E-Sports. Stay long TenCent and Naspers!




Home again, home again, jiggety-jog. Markets across Asia are all up. Japanese markets are up a lot. TenCent is up nearly a percent and a half, that matters to us down here. Like a lot.




Sent to you by Sasha, Byron and Michael on behalf of team Vestact.

Email us

Follow Sasha, Michael, Byron, Bright and Paul on Twitter

078 533 1063

Monday, 31 October 2016

Hips, Shoulders, Knees and Toes


"Stryker reported results for their third quarter last Thursday, after the market closed. This is the kind of business that has changed significantly, keeping relevant and up to date as medical science has evolved. Knee and hip operations are more prevalent than any other time in history."




To market to market to buy a fat pig Friday was another day that the equity markets slid from underneath us. It seems that politics is to blame at the fringes (stronger Rand, which is a good thing), perhaps a semblance of relief that the fellow with the keys to the treasury is doing such a good job. CNBC had an interview with the minister of finance, live at the JSE on Friday, it was really good. Good in the way that he still held it together, stressed teamwork is the key, he was funny. He seemed to carry the aura of a person in charge of their respective domain. Of course, you and I know that a cabinet shuffle could happen at any time. So, we have to live with the situation and know that politics, as much as it makes you crazy, also takes care of itself. We do not have any control over it. Politics, like many other things when investing, is one of the big "things" that you can't even closely control.

This short piece is a must read - Book Review: Is Forecasting A General Skillset? It is about making forecasts and looking at professionals and amateurs alike. And there are some key points, like " ... simplicity is essential to forecasting" and "Consistently, the best forecasters don't use sophisticated statistical approaches, and anything beyond basic data crunching is usually a misapprehension of reality." Another set of lines from the piece, for more background: "Investing is a polyvalent, polymathic enterprise - you need to touch upon statistics, economics, history, psychology, political science, to name a few. Yet, what we train today are specialists in narrow fields who generally can't see the bigger picture."

Which leads us to the very last piece that nails the conclusion, at the end of the article: "It doesn't matter whether the market is up 12% or 16% in any given year; what matters is that it's up, and in sufficient magnitude to make certain portfolio themes function the way they ought to. To spend time trying to figure out the difference between a few percentage points of return is to miss the forest for the trees and expend tremendous resources on effectively nothing." Basically, spending hours and days trying to build complicated models that may miss by a little, and then wondering why they miss is a waste of time. Rather get the big picture right and then know that at the fringes there is very little that you can do about it, to get a perfect forecast. Like the weather, which is extremely unpredictable, so are markets in the short term.

Enough of that, a quick market scoreboard - the Jozi all share sank two-thirds of a percent, lead lower by financials. In what was a pretty broad based sell off, AB InBev, after a very average trading update, was down over four percent on the day. At the other end of the table, on a sparsely populated winners side, was Tiger Brands. Their trading update which looked very decent, saw to it that the share price climbed nearly two and a half percent on the day. The other bigger news on the day was that Dischem was looking to sell 27.5 percent of the business to qualifying investors. Management, one investor (deep value Cape Town fellow, you guess!) and the founding family would be the other shareholders. Nice, it is good to have choices. At the top end of the range the company may well be worth 20 billion Rand, valuing the company at more than the market currently values Barloworld, Tongaat or Famous Brands. That is the type of company that they would be keeping. And twice the size of Cashbuild. How many other private businesses out there can you think of which are at that size and scale?




Over the seas and far away in New York, New York, stocks were rattled by a mid session FBI probe into Clinton emails, uncertainty = sell first and then ask questions later. By the time all was said and done, the nerds of NASDAQ had lost half a percent, the broader market S&P 500 closed down just under one-third of a percent, whilst the Dow Industrials fell a smidgen, down 0.05 percent. The big news from over the weekend was that General Electric and Baker Hughes have neared a 30 billion Dollar deal. Both stocks were up Friday, and whilst GE initially suggested that there was not too much going on ("We are in discussion with Baker Hughes on potential partnerships. While nothing is concluded, none of these options include an outright purchase."), Mr. Market seems to be ok with a deal. GE and Baker Hughes will have a combined investor webcast this afternoon. Deals = confidence.




Company corner

Stryker reported results for their third quarter last Thursday, after the market closed. This is the kind of business that has changed significantly, keeping relevant and up to date as medical science has evolved. Knee and hip operations are more prevalent than any other time in history. More and more each and every day! Complicated stuff for us mere mortals. When you think of the business, think of a company that has three divisions, Medical and Surgical (MedSurg), which includes all the power tools, the hospital beds, the ambulance cot (beds) to more hardcore software for complicated procedures. There is also a wide array of surgical equipment, cement mixers, waste management (blood and the like), as well as even cleaners and detergents.

Then there is the more complicated hips, knees, soft tissue and computer assisted repair (amongst others) business, the orthopedics business. This division includes newer technologies like the Mako Robotic-Arm assisted surgery device. The whole aim is to make sure that the quality is maintained, each and every operation looks like the last one. See? Knee replacements are like big Macs. Only kidding, obviously you want and need the consistency time and time again, maintain quality. The last knee implant must look like the next. Eliminating human error. The question is, with the technology available to us, with regards to the precision afforded to us by fine tuned machines, are they (the machines) as good as the surgeon? Time will tell.

Lastly, there is the Neurotechnology and Spine division. This is the division that I find incredible, cutting edge and incredibly futuristic. This stuff blows my mind - > Interbody/Vertebral Body Replacement. I am speechless that parts in humans can be 3D printed (Cranial replacement) to last.

So that is the split. As per the last quarter (below) 38.01 percent orthopedics, 44.23 percent Medsurg, and the balance (17.76 percent) Neurotechnology. And then, North America is still the main part of this business. Which is why I really like it, there are huge growth prospects for this business around the globe.



The company guided forward for the full year in a tighter range, at the top end. So not too much of a spectacular change, the stock still trades on around 19.3 times forward (to the end of the year), the dividend is not why you own it, a paltry 1.33 percent yield currently. Mind you, the dividend has doubled in the last five years, that tells you a lot. This is a very exciting space to be invested, if you think about it at the simplest level, people are living longer and require solutions from science in order to be able to replace parts that have been subjected to wear and tear. As science evolves, there will be more parts and more solutions, more equipment to do the surgeries. The company also has the ability to do small deals and add to their portfolio where they see fit. We continue to recommend the stock as a solid long term investment and are currently buying.




Linkfest, lap it up

As time goes by, technology keeps getting better and our ability to communicate improves. The next major step in communication will be the shift from 4G to 5G - This video shows the difference between 4G and 5G

This new computer from Microsoft looks great - The Surface Dial is a crazy puck that controls Microsoft's new PC.The test will come with its functionality and user friendliness though. As we discussed last week, IBM saved money by using Macs instead of PC's running windows due to the huge IT support cost that comes with Windows based machines.

I have seen much debate recently about passive vs active investing The Pitfalls of the Passive Investing Marketing Pitch. The main point of the article is that if you think an ETF is for you, make sure you know what you own. You might be owning a unit trust in a different name and it still has multiple layers of fees that you don't see.

Today is halloween so here are some commercial numbers from the US - Halloween Is Frightfully Lucrative. Making the tradition go mainstream is a huge win for marketers, the amount of money spent on sweets and costumes is mind blowing.






Home again, home again, jiggety-jog. Halloween today. No scares Monday. Sadly politics will weigh on markets, with two of the not so best candidates in the US pit against one another in a fight to the close. There are of course non-farm payrolls this week Friday and earnings continue. Facebook, Alibaba, Starbucks report numbers, as do many, many others. From an interest point of view we have Coach, Whole Foods and Solar City, Activision Blizzard and GoPro too. Those are all "interesting". Never a dull day!



Sent to you by Sasha, Byron and Michael on behalf of team Vestact.

Email us

Follow Sasha, Michael, Byron, Bright and Paul on Twitter

078 533 1063

Friday, 22 July 2016

Stryke while the price is down

"As you know, we really like the sector, it is changing, growing and getting exceptionally better as we speak. Our job is to find the best companies who are spearheading this change. Stryker is certainly one of them, we reiterate our buy rating."




To market to market to buy a fat pig Oh no, the little steam engine of the Dow Jones variety did not make it to the top of the hill. There is an enormous amount of company related news that we have to deal with, we should definitely bounce directly into these events immediately. As we say, we do companies and not economies and announcements from governments. And global bodies and their predictions. Besides, who remembers what the last one was, or the one from five years ago? Or what it is likely to be in five years time? You don't know what is going to transpire, I don't know, collectively we can work towards what we think is reasonable.

Before we do a quick scoreboard check, there was a rates decision locally yesterday. The trajectory for inflation was lowered in the long run (out of the band in the short term), that is a good thing. What is not good is that the trajectory for growth was also lowered. To flat. Eish, it is tough out there chaps. It certainly doesn't always feel like it in the big bad Jozi, things are always going on. Whilst this lovely province off ours hustles and bustles and is filled with economic activity that is ahead of the rest of the country in terms of the contribution, it does not represent all of South Africa. Don't make that mistake, the cranes in Sandton might represent what is happening in the most powerful economic hub across the continent, it certainly isn't the lived reality of many ordinary South Africans.

That said, we should be grateful that we are not Turkey, or Russia, it hardly looks that encouraging politically in those parts of the world. We have elections in a couple of weeks, if not national ones, perhaps the more important bread and butter issues around municipalities. At the end of the day, all people want is accountability. If we deliver you consistently poor returns, no matter what we say, you are going to pull money.

The same is true for Bill Ackman, the hedge fund manager according to Yahoo! finance made his conference call sound like a victory lap, after getting "stomped". He may well be right on Herbalife, the market always has deeper pockets than you. Remember that. That almost buried Michael Burry, he was right in the end. The eccentric drum playing fund manager, who could have been a full time neurologist, was wrong forever during a time the market flew. He ended up being very right. If you haven't read the Big Short or watched the movie, definitely read up about the weird antics and his ability to crunch the numbers better, and to hustle. Strangely, last I read of him is that he advocated growing food and sending it across to places with less water. Yip.

Scoreboard check quickly, the Dow Jones fell for the first time in over 8 sessions, down over four-tenths of a percent by the end of the session. The nerds of NASDAQ lost just over one-third of a percent and the broader market S&P 500 was somewhere in-between the two. Well, records are there to be broken, earnings are going to continue to drive share prices and broader markets. Financials, in a very tough environment have been able to stay extremely profitable. Intel was weaker during the session, the stock has been completely flat since the beginning of the year, over the last 12 months the stock has returned a little over 16 percent, that sounds pretty darn good. The last two years have been a slog however, most chip makers in the PC and server space have struggled. The Internet of Things is likely to change that.

Talking of which, on the local front Vodacom reported subscriber numbers that were good, having gained market share here in South Africa. As we saw however from that Cisco report about the internet of things the other day when we covered the MTN trading update - 6 month trading update - swing to loss, there will be 1.5 devices connected per person by 2020. If you think that is a lot, just look around at your phone, your computer, perhaps an iPad and even a fitness device. There, you account for four already, comfortably ahead of the rest.

Locally stocks slid off the highs into the close, we did still however manage to end the day in the green, up just a smidgen over one-quarter of a percent by the time all was said and done. Industrials lower, resources much (much) higher on the session. Financials up the same amount as the market. Vodacom was the biggest loser on the day, down two and one-quarter of a percent, Amplats soared over six percent, whilst Glencore added over four. Shoprite gave a little back after a magic day in the session prior (up over ten percent), the stock is still flirting with multi month highs. And with the inflation outlook improving, perhaps they would be the first beneficiaries. The market is telling you exactly this, Pikwik, Massmart and Pick n Pay all clocking new 12 month highs during the session. Into company news sports lovers, dive below the line to find it.




Company corner

Discovery made an announcement yesterday that needed closer and further inspection. The headline reads Discovery to introduce Vitality to Japan. Japan of course is a country with over 125 million people, where the average age is around 45 and is possibly one of (if not the) most sophisticated societies on the planet. Organisational skills and attention to detail is not lacking.

OK, so how do discovery plan to do all of this? Simple, at least if you read it at face value - "a strategic partnership with Sumitomo Life Insurance Co. (Sumitomo Life) and SoftBank Corporation (SoftBank) that will see shared value insurance introduced to the Japanese life insurance market through the joint development of insurance products incorporated with Vitality, Discovery's globally recognised wellness programme."

Sumitomo is an insurer that is over 100 years old, it produces profits in excess of 3 billion Dollars per annum, it is headquartered in Osaka (my aunt used to live there), employs over 42 thousand people and most impressive, has policies in place in excess of 1.1 trillion Dollars. Individual life insurance is where their business is at, from their website:



If the Vitality program can boost the company profitability by making those with life insurance eke out a few more years (by having healthier habits) then the payout ratio is extended. Life insurance is a what if I die before I have accumulated enough assets purchase, before I pay down my debt. It is designed to give the remaining behind people, if you happen to die before the actuarial calculations say you will, the same life style that they would have afforded you in the past. There are different forms of life insurance that are also designed to act as investment products, obviously the costs increase as you get older, none of us are Benjamin Button.

For companies such as Sumitomo, it makes sense to use the tried and tested Vitality model. The model is not too dissimilar to the Tesla one, each and every day that data is being sent back to the databases to be crunched by Vitality, the better the systems become. By being healthy, eating right, most importantly exercising and generally being responsible, the company is able to get a better idea of your risk to them. Doing it slightly differently is Discovery, eking out small percentages on giant amounts makes these companies a LOT more profitable and subsequently, the savings are shared as spoils, this is where you benefit as a Discovery shareholder. Softbank, you may recognise that company, they are real operators and I suspect a great partner to be introduced to for the Discovery team. A net positive, the share price rallied one and a half percent on the day.




Visa takes you places. Visa will be in your face over the coming weeks as a Worldwide Olympic Partner, those are two weeks away sports lovers. An amazing thing really, the Olympic Games, this one will of course be no exception. Equally, Visa is an amazing company. Their ability to run a network that will switch your transaction in a single swipe, regardless of whether you are in any of the major cities of the world and regardless of where your bank is. The fact that there can be guaranteed payment to the merchant, no cash ever exchanges hands and your risks are greatly reduced, that part you just take for granted. We don't even bat an eye.

Yet payment methods continue to evolve to the point where no physical card will be produced, you can with your thumbprint exercise your right to acquire the goods. Just like that. Remember travellers cheques? I remember going on Honeymoon with a whole lot (back then a kings ransom) of them, changing them, fees and all. Visa, along with all the switching networks will be at the forefront of the new technologies, nobody wants to reinvent the wheel just yet. Apple Pay still requires your "card", even if in the future you won't ever produce the physical. If you know your card verification value (the last three digits on the back) in many cases you can complete an online transaction without ever having to see your card again.

Visa numbers from last evening quickly, this was for their third quarter. The meet on the revenue line was also met with a beat on earnings, slightly ahead of Wall Street expectations. The company has also made the share buyback larger, to 7.3 billion Dollars. The market cap last evening was 189 billion Dollars, this represents a really large amount, shareholders only feel the impact much later. Fewer shares in issue with incrementally increasing earnings.

Volumes continue to increase in the low double digits, as consumers and governments are encouraged to do more digitally. We often point out that many transactions are still cash in Europe, the more done with cards, the cheaper it gets eventually for everyone. Visa Europe was integrated into the company, the total consideration remember was upfront 12.2 billion Euros, plus an extra Pref share issuance of 5.3 billion Euros and a closing 1 billion plus 4 percent per annum in interest on the third anniversary of closing. In total around 21 and a half billion Dollars. A truly big deal! Part of the buyback is to minimise the impact of the prefs issued here.

The stock has always looked perpetually expensive. Now is no exception either. Even with guidance given of high single digit revenue growth, margins to die for and the ability to generate free cash of 7 billion Dollars per annum, the market always has high expectations. There are an astonishing 2.5 billion cards out there. According to this report from competitor MasterCard, "cash still accounts for 85% of all consumer transactions throughout the world." A non-cash (i.e. Electronic and Card) payment transactions are understandably at a much lower percentage in developing countries than developed countries. Still, there is plenty of room for growth, as you can see -



We suspect that Visa and the others who operate the networks for switching will continue to benefit from all the switching away from cash. I am pretty sure that cash as we know it is living on borrowed time, at least in more developed societies. The carrying costs are too high, it needs to be guarded and buried in a hole in the ground. Sounds like gold. We continue to accumulate what is a very well positioned business that benefits from globalisation and changing consumer patterns. The stock price is flat after-hours.




Sometimes markets work in mysterious ways. Last night Stryker beat earnings estimates, but lowered expectations for next quarter. The stock is down 4% premarket. The reason I am perplexed is because they actually raised estimates for the full year. Estimates for the year increased, but the market is only focussing on next quarter. Sounds like an opportunity to me. Long term shareholders will not be too upset however, the stock is up nearly 30% year to date and it is the best performing stock in the Vestact portfolio so far this year. Let us look at the numbers.

When reporting sales the medical devices business splits their sales into 3 categories. Net sales for the group grew 16.8% to $2.8bn, 6.6% if you exclude acquisitions. The image below not only shows you these three categories but it further details the divisions.



As you can see, the acquisition of Sage Products and Physio Control International had a strong impact on the MedSurg division. If you click on the links and browse through the websites it is pretty impressive seeing all the new products and devices they are coming up with to improve our standard of living. Your body is your greatest tool, these are the devices that will fix it. What bigger priority can you have than the physical well being of yourself and your loved ones? Back to the numbers.

This growth in sales resulted in a 15.8% increase in earnings to $1.39 for the quarter. That is excluding the costs and intangible write downs form the acquisitions. Gross margins are a whopping 66.2% and operating income margin came in at 24.8%. They sure do charge you for these high end products. It is an incredibly profitable business. 10% of these gross profits goes back into Research and Development. Trading at $118 a share and expecting full year earnings of $5.75 the stock trades just above 20 times. Slightly above the S&P500 forward average of 17, and current trailing 19.3 times.

When you look at the quality of the business, I am not surprised. The majority of doctors we speak to rave about their products. If you work in healthcare and have some extra insights please let us know what you think of Stryker products. Having said that, 72% of their sales comes from the US (although they seem to have a decent presence in SA). This presents a good opportunity for global expansion.

Another exciting prospect could come from further acquisitions. There is a huge amount of innovation in the healthcare sector and products are being created all the time independently. Stryker has a market cap of $46bn and is sitting on $3bn in cash. I am sure there are lots of consolidation opportunities.

As you know, we really like the sector, it is changing, growing and getting exceptionally better as we speak. Our job is to find the best companies who are spearheading this change. Stryker is certainly one of them, we reiterate our buy rating.




Linkfest, lap it up

Two of our US holding are teaming up to help save students money (and grow their market share) - Amazon and Wells Fargo Team Up to Offer Cheaper Student Loans

Following on from our Tesla piece yesterday, batteries are a very big factor as to whether Elon Musk's dreams will come true - Our Energy Problem: Putting the Battery in Context. As you can see batteries still have a very long way to go until they are in the leagues of other energy sources.



Streaming has already won the music wars, who will win the streaming wars is the next question. Who wins the streaming wars will also impact how artists will be paid for their content going forward - Apple wants a 'simpler and more transparent' royalty scheme for music that would also seriously hurt Spotify.

The more people I speak to about finances, the more you realise that it is an area where society does not understand enough - Nearly two-thirds of Americans can't pass a basic 5-question financial literacy test, can you?. I was apprehensive to take the test but glad to say that I managed to get 6 out of 6.




Home again, home again, jiggety-jog. Stocks across the globe are lower, we are off the best levels, I am guessing that we shouldn't complain now should we. So far on the earnings front there haven't been too many disappointments and I am sure in the coming months we are going to see a return to normality. Whatever Mario Draghi and his team, and Janet Yellen and her team do, they will do. That goes without saying, they definitely are given stick, yet everyone equally wants their comfort blankey from the central banks.



Sent to you by Sasha, Byron and Michael on behalf of team Vestact.

Email us

Follow Sasha, Michael, Byron, Bright and Paul on Twitter

078 533 1063